ClinicalTrials.gg
RecruitingNCT07052825Updated Jul 7, 2025

The Role of Capsular Tension Rings in Intraocular Lens Stability in High Myopia Cataract Patients: A Prospective Self-Controlled Study

An interventional study of CTR implantation in High Myopia and Cataract, sponsored by Jin Yang. Recruiting at 1 site in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2025-07-07.

Sponsored by Jin Yang · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jan 2025, registered Jun 2025).
  • Started Jan 2025; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Non-randomized
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 184 studies in Cataract with a site in China — 39 open to participants now, 49 under way, none of them phase 3. Cataract · China.

Planned enrollment
40th of 111
120 · median 90
Started
2025
with 14 others
No phase
104 of 184
19 open now
Primary completion
2030-12
later than 44 of 48 live
Registered
158th of 184
by date
Lead sponsor
6 of 184
Jin Yang

Among the 184 studies in Cataract with a site in China, this one is the 40th largest by planned enrollment of the 111 interventional ones that give a count, is one of 15 that started in 2025, is one of 104 with no phase, reaches primary completion later than 44 of the 48 other live ones, and was the 158th registered.

Cataract

1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.

Browse Cataract studies →

Open to participants now

39 of the 184 studies in Cataract with a site in China are open now. Recruiting first, the newest first:

33 more — sign in →

All 39 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 184 studies in Cataract with a site in China, or all of them as a file.
02

Study summary

Study Purpose:

This prospective, self-controlled clinical study aims to evaluate the impact of capsular tension rings (CTR) on intraocular lens (IOL) stability in high myopia patients undergoing bilateral cataract surgery. Each patient will receive CTR implantation in one eye, with the fellow eye serving as control. Postoperative outcomes, including visual acuity, refraction, IOL positioning, and visual quality, will be compared between eyes to assess the effectiveness of CTR.

Study Methods:

Eligible participants (axial length ≥ 26.0 mm) will undergo femtosecond-assisted phacoemulsification with identical IOLs implanted in both eyes. One eye will be randomly assigned to receive a CTR. All surgeries will be performed by the same surgeon. Follow-up will be conducted at 1 day, 1 week, 1 month, 3 months, and 6 months postoperatively. Assessments will include UCVA, BCVA, refractive error, anterior segment OCT, IOL decentration and tilt, and visual quality (iTrace).

Sample Size and Population:

A total of 60 patients (120 eyes) will be enrolled. Inclusion criteria include age ≥ 18 years and bilateral cataracts with high myopia. Exclusion criteria include other ocular diseases, history of severe ocular trauma, or poor visual potential. Patients will be stratified by axial length into three groups: ≤28 mm, 28-30 mm, and >30 mm.

Study Procedure:

After informed consent and baseline examinations (including ocular biometry and imaging), patients will undergo surgery and be followed at specified intervals. All data will be managed securely. Comparative analysis between CTR and non-CTR eyes will be performed to evaluate the effect of CTR on IOL stability and visual outcomes in highly myopic cataract patients.

Read the detailed description

Study Purpose:

This study aims to evaluate the effect of capsular tension rings (CTR) on intraocular lens (IOL) stability in cataract patients with high myopia. Each patient will undergo cataract surgery in both eyes, with one eye receiving a CTR and the other eye not receiving a CTR, using the same IOL model in both eyes. Postoperative visual quality and IOL stability will be compared between the two eyes. The study will analyze changes in postoperative visual acuity, refraction, ocular parameters, anterior segment morphology, and IOL positioning to assess the effect of CTR implantation on visual outcomes in highly myopic patients.

Study Methods:

This is a prospective, self-controlled clinical study involving cataract patients with high myopia (axial length ≥ 26.0 mm) scheduled for bilateral cataract surgery. Patients will undergo femtosecond-assisted phacoemulsification and IOL implantation in both eyes, with one eye randomly assigned to receive a CTR and the other not. All procedures will be performed by the same surgeon to ensure consistency. Postoperative follow-up visits will be scheduled at 1 day, 1 week, 1 month, 3 months, and 6 months. Evaluation indicators include uncorrected and best corrected visual acuity (UCVA, BCVA), refractive status, intraocular pressure, anterior segment morphology (anterior segment OCT), IOL decentration and tilt (using anterior segment images), and visual quality (iTrace).

Sample Size and Study Population:

The estimated sample size is 60 patients (i.e., 120 eyes). Each patient will receive CTR implantation in one eye and serve as their own control in the fellow eye. Inclusion criteria: age ≥ 18 years, bilateral cataracts with high myopia eligible for surgery. Exclusion criteria: ocular comorbidities (e.g., glaucoma, retinal disease), history of major ocular trauma or surgery, and other causes of vision loss. Patients will be grouped based on axial length: Group A (AL ≤ 28 mm), Group B (28 mm \< AL ≤ 30 mm), and Group C (AL > 30 mm).

Study Procedure:

Participants will be recruited after signing informed consent and passing pre-screening assessments. All subjects will receive detailed explanations regarding study purpose, procedures, risks, and postoperative care. Baseline examinations will include biometry, axial length, anterior segment measurements, and corneal topography. After surgery, patients will be followed up at 1 day, 1 week, 1 month, 3 months, and 6 months. Examinations include visual acuity, refraction, intraocular pressure, IOL position (decentration and tilt via anterior segment OCT), and visual quality analysis (iTrace). All data will be securely managed, and the final analysis will compare visual outcomes and IOL stability between the CTR and non-CTR eyes in highly myopic patients.

03

Conditions studied

  • High Myopia
  • Cataract

Browse trials for

Keywords

  • Capsular Tension Ring(CTR), High Myopia, Intraocular lens, Tilt, Decentration, Visual Quality
04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age ≥ 18 years.
  2. Diagnosed with bilateral age-related cataracts and scheduled for phacoemulsification with IOL implantation in both eyes.
  3. High myopia in both eyes, defined as axial length (AL) ≥ 26.0 mm.
  4. No significant difference in axial length between the two eyes (e.g., interocular AL difference \< 1.0 mm).
  5. Willingness and ability to undergo bilateral surgery within a short interval (e.g., within 1-2 weeks).
  6. Able to provide and comply with the study protocol and follow-up visits.

Exclusion criteria

Exclusion Criteria:

  1. History of ocular trauma, surgery, or intraocular inflammation in either eye.
  2. Presence of other ocular diseases that may affect visual outcomes, such as glaucoma, diabetic retinopathy, macular degeneration, or corneal opacity.
  3. Evidence of zonular weakness, pseudoexfoliation, or significant phacodonesis preoperatively.
  4. Severe dry eye or poor fixation that may interfere with postoperative imaging.
  5. Systemic diseases affecting visual function (e.g., uncontrolled diabetes, neurologic disorders).
  6. Participation in other clinical trials that may affect the study outcomes.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    CTR implantation

    Phaco+IOL with CTR implantation

    Procedure: CTR implantation

  • No intervention
    NCTR

    Phaco+IOL without CTR implantation

Interventions

  • ProcedureCTR implantation

    Phaco+IOL with CTR implantation

06

What researchers measure

Primary outcomes

  1. Tilt and Decentration

    measured by using anterior segment OCT

    Time frame: Postoperative follow-up visits will be scheduled at 1 day, 1 week, 1 month, 3 months, and 6 months

Secondary outcomes

  1. Anterior Capsular Contraction

    Measured by Anterior Segment Photography and ImageJ

    Time frame: 1 day, 1 week, 1 month, 3 months, and 6 months postoperatively

  2. visual acuity

    UDVA AND BCVA

    Time frame: 1 day, 1 week, 1 month, 3 months, and 6 months postoperatively

  3. Visual Quality

    Measured by iTace

    Time frame: 1 day, 1 week, 1 month, 3 months, and 6 months postoperatively

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Dec 2030, 71 months after the start.

Of 304 non-industry interventional studies with no phase under Cataract, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 71 months is above that.

Counting every sponsor, half of 494 studies reached it within 17 months; a quarter within 9 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 29, 2025
First posted
Jul 7, 2025
StartActual
Jan 1, 2025
Primary completionEst.
Dec 31, 2030
CompletionEst.
Dec 31, 2030
Last update
Jul 7, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07052825
Lead sponsor
Jin Yang
Responsible party
Jin Yang (Chief Physician, Eye & ENT Hospital of Fudan University) — Sponsor-investigator
First posted
Jul 7, 2025
Start date
Jan 1, 2025
Primary completion
Dec 31, 2030 (estimated)
Completion
Dec 31, 2030 (estimated)
Last update
Jul 7, 2025

Study contacts

Xuanqiao Lin
Contact
1532483480@qq.com
+8615088920668
Baoxian Zhuo
Contact
1532483480@qq.com
Jin Yang
study chair · Fudan University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion